SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report

Background Seizure-related 6 homolog-like 2 (SEZ6L2) antibody-associated cerebellar ataxia is a rare autoimmune disorder with very limited cases reported in the literature. Responses to conventional immunotherapy are variable. Case presentation We present the case of a patient initially misdiagnosed with alcohol-related brain damage (ARBD) and type 2 diabetes-associated peripheral neuropathy. Following the detection of anti-SEZ6L2 antibodies in both serum and cerebrospinal fluid, the diagnosis was revised to SEZ6L2 antibody-associated cerebellar ataxia. The patient exhibited clinical improvement following combination therapy with double filtration plasmapheresis (DFPP) and glucocorticoids. Conclusion This case highlights the diagnostic challenges of SEZ6L2 autoimmunity, which can mimic toxic or metabolic encephalopathies. Clinical improvement following combined DFPP and glucocorticoid treatment supports a potential therapeutic role for this approach but cannot prove antibody pathogenicity or the independent efficacy of DFPP.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1869743
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report

Bin Liu, Yuhong Ma, Yuhui Wang, Tiantian Jiang et al.
2 links
Frontiers in Immunology
Autoimmune Neurological Disorders and Treatments
article

SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report

Bin Liu, Yuhong Ma, Yuhui Wang, Tiantian Jiang, Chunping Zhu
article en

Abstract

Background Seizure-related 6 homolog-like 2 (SEZ6L2) antibody-associated cerebellar ataxia is a rare autoimmune disorder with very limited cases reported in the literature. Responses to conventional immunotherapy are variable. Case presentation We present the case of a patient initially misdiagnosed with alcohol-related brain damage (ARBD) and type 2 diabetes-associated peripheral neuropathy. Following the detection of anti-SEZ6L2 antibodies in both serum and cerebrospinal fluid, the diagnosis was revised to SEZ6L2 antibody-associated cerebellar ataxia. The patient exhibited clinical improvement following combination therapy with double filtration plasmapheresis (DFPP) and glucocorticoids. Conclusion This case highlights the diagnostic challenges of SEZ6L2 autoimmunity, which can mimic toxic or metabolic encephalopathies. Clinical improvement following combined DFPP and glucocorticoid treatment supports a potential therapeutic role for this approach but cannot prove antibody pathogenicity or the independent efficacy of DFPP.

Frontiers in ImmunologyVol. 17
Punan Hospital (CN), Chinese People's Liberation Army (CN)
Good health and well-being
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon